Ocular surface disease is a common comorbidity of glaucoma. The management of dry eye in glaucoma presents a unique challenge to eye care practitioners, as IOP-lowering drops have extensive mechanisms for causing or exacerbating damage to the ocular surface. Here, we discuss specific mechanisms involved and ocular surface friendly tips for glaucoma management.   

Speaker: Kaleb Abbott, OD, MS, FAAO, FOWNS

Date: Monday, October 19, 2026

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour CE credit.

Thank you to Thea for exhibiting at this event.

Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.